References
- Braakhuis B JM, Sneeuwloper G, Snow GB. The potential of the nude mouse xenograft model for the study of head and neck cancer. Arch Otorhinolaryngol 1984; 239: 69–79
- Wennerberg J, Tropé C, Biörklund A. Heterotransplantation of human head and neck tumours into nude mice. Acta Otolaryngol (Stockh) 1983; 95: 183–90
- Lindenberger J, Ganzer U, Fortmeyer HP. Die Heterotransplantation bösartiger Kopf- und Halsgeschwülste auf thymusaplastische nackte Mäuse. Arch Otorhinolaryngol 1978; 220: 117–28
- Braakhuis B JM, Schoevers E J, Heinerman E CM, Sneeuwloper G, Snow GB. Chemotherapy of human head and neck cancer xenografts with three clinically active drugs: cis-platinum, bleomycin and methotrexate. Br J Cancer 1983; 48: 711–16
- Hong W K, Bromer R. Chemotherapy in head and neck cancer. N Engl J Med 1983; 308: 75–79
- Reinhold HS. A cell dispersion technique for use in quantitative transplantation studies with solid tumours. Eur J Cancer 1965; 1: 67–71
- Barendsen G W, Broerse JJ. Experimental radiotherapy of a rat rhabdomyosarcoma with 15 MeV neutrons and 300 kV X-rays. I. Effects of single exposures. Eur J Cancer 1969; 5: 373–391
- Lindenberger J. Aspects of xenografted tumors of the ear, nose and throat. Morphology, cell kinetics, growth behaviour and immunology. Thymusaplastic nude mice and rats in clinical oncology, GBA Bastert, et al. Fischer Verlag, Stuttgart/New York 1981; 449–466
- Kopper L, Steel GG. The therapeutic response of three human tumor lines maintained in immune-suppressed mice. Cancer Res 1975; 35: 2704–2713
- Bertino J R, Fischer GA., VI. Techniques for the study of resistance to folic acid antagonists. Methods Med Res 1964; 10: 297–307
- Wennerberg J, Aim P, Biörklund A, Killander D, Långström E, Tropé C. Cell cycle perturbations in heterotransplanted squamous-cell carcinoma of the head and neck after mitomycin C and cisplatin treatment. Int J Cancer 1984; 33: 213–222
- Osieka R, Houchens DP, Goldin A, Johnson RK. Chemotherapy of human colon cancer xenografts in athymic nude mice. Cancer 1977; 40: 2640–2650
- Schornagel J H, McVie JH. The clinical pharmacology of methotrexate. Cancer Treat Rev 1983; 10: 53–75
- Schornagel J G, Leyva A, Pinedo HM. Methotrexate with thymidine protection or rescue in advanced head and neck cancer: a phase II study. Cancer Treat Rep 1984; 68: 543–545
- Diddens H, Niethammer D, Jackson RC. Patterns of cross-resistance to the antifolate drugs trimetrexate, metoprine, homofolate, and CB 3717 in human lymphoma and osteosarcoma cells resistant to methotrexate. Cancer Res 1983; 43: 5286–5292
- Chabner BA. Antimetabolites. Cancer chemotherapy, HM Pinedo. Excerpta Medica, Amsterdam 1980; 1–26
- Fry D W, Anderson L A, Borst M, Goldman ID. Analysis of the role of membrane transport and polyglutamation of methotrexate in gut and the Ehrlich tumor in vivo as factors in drug sensitivity and selectivity. Cancer Res 1983; 43: 1087–1092
- Wennerberg J. Changes in growth pattern of human squamous-cell carcinomas of the head and neck during serial passages in nude mice. Int J Cancer 1984; 33: 245–250
- Heinerman E CM, Braakhuis B JM, Boerrigter G H, Snow GB. Successful in vitro growth of human head and neck cancer after transplantation in nude mice. Arch Otorhinolaryngol, (in press)